| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72000-120-06 | 72000-120 | HUMAN PRESCRIPTION DRUG | Xenleta | lefamulin acetate | INJECTION, SOLUTION | INTRAVENOUS | 20190909 | N/A | NDA | NDA211673 | Nabriva Therapeutics US, Inc. | LEFAMULIN ACETATE | 150 mg/15mL | 6 VIAL, SINGLE-USE in 1 CARTON (72000-120-06) / 15 mL in 1 VIAL, SINGLE-USE (72000-120-01) |
| 72000-030-06 | 72000-030 | HUMAN PRESCRIPTION DRUG | Citric Buffered Normal Saline | anhydrous citric acid | INJECTION, SOLUTION | INTRAVENOUS | 20190909 | N/A | NDA | NDA211673 | Nabriva Therapeutics US, Inc. | ANHYDROUS CITRIC ACID | 166 mg/270mL | 6 BAG in 1 CARTON (72000-030-06) / 270 mL in 1 BAG (72000-030-01) |